▶ 調査レポート

世界のジフテリア・破傷風・百日咳混合ワクチン市場(~2028年):不活性化ワクチン、その他

• 英文タイトル:Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Insights, Forecast to 2028

Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Insights, Forecast to 2028「世界のジフテリア・破傷風・百日咳混合ワクチン市場(~2028年):不活性化ワクチン、その他」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2Q12-18994
• 出版社/出版日:QYResearch / 2022年12月
• レポート形態:英文、PDF、97ページ
• 納品方法:Eメール(納期:3営業日)
• 産業分類:医薬品&医療
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、ジフテリア・破傷風・百日咳混合ワクチンのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。
ジフテリア・破傷風・百日咳混合ワクチンのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
ジフテリア・破傷風・百日咳混合ワクチンの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
ジフテリア・破傷風・百日咳混合ワクチンのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。

生産面において、本レポートは2017年から2022年までのジフテリア・破傷風・百日咳混合ワクチンの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のジフテリア・破傷風・百日咳混合ワクチンの売上および2028年までの予測に焦点を当てています。

ジフテリア・破傷風・百日咳混合ワクチンのグローバル主要企業には、Sanofi Pasteur、GSK、Mitsubishi Tanabe Pharma、KM Biologics、Wuhan Institute of Biological Products、Walvax Biotechnology、Chengdu Institute of Biological Products、Minhai Biotechnologyなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

ジフテリア・破傷風・百日咳混合ワクチン市場は、タイプとアプリケーションによって区分されます。世界のジフテリア・破傷風・百日咳混合ワクチン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。

【タイプ別セグメント】
不活性化ワクチン、その他

【アプリケーション別セグメント】
12ヶ月以下、12ヶ月以上

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- ジフテリア・破傷風・百日咳混合ワクチン製品概要
- タイプ別市場(不活性化ワクチン、その他)
- アプリケーション別市場(12ヶ月以下、12ヶ月以上)
- 調査の目的
・エグゼクティブサマリー
- 世界のジフテリア・破傷風・百日咳混合ワクチン販売量予測2017-2028
- 世界のジフテリア・破傷風・百日咳混合ワクチン売上予測2017-2028
- ジフテリア・破傷風・百日咳混合ワクチンの地域別販売量
- ジフテリア・破傷風・百日咳混合ワクチンの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ジフテリア・破傷風・百日咳混合ワクチン販売量
- 主要メーカー別ジフテリア・破傷風・百日咳混合ワクチン売上
- 主要メーカー別ジフテリア・破傷風・百日咳混合ワクチン価格
- 競争状況の分析
- 企業M&A動向
・タイプ別市場規模(不活性化ワクチン、その他)
- ジフテリア・破傷風・百日咳混合ワクチンのタイプ別販売量
- ジフテリア・破傷風・百日咳混合ワクチンのタイプ別売上
- ジフテリア・破傷風・百日咳混合ワクチンのタイプ別価格
・アプリケーション別市場規模(12ヶ月以下、12ヶ月以上)
- ジフテリア・破傷風・百日咳混合ワクチンのアプリケーション別販売量
- ジフテリア・破傷風・百日咳混合ワクチンのアプリケーション別売上
- ジフテリア・破傷風・百日咳混合ワクチンのアプリケーション別価格
・北米市場
- 北米のジフテリア・破傷風・百日咳混合ワクチン市場規模(タイプ別、アプリケーション別)
- 主要国別のジフテリア・破傷風・百日咳混合ワクチン市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのジフテリア・破傷風・百日咳混合ワクチン市場規模(タイプ別、アプリケーション別)
- 主要国別のジフテリア・破傷風・百日咳混合ワクチン市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のジフテリア・破傷風・百日咳混合ワクチン市場規模(タイプ別、アプリケーション別)
- 主要国別のジフテリア・破傷風・百日咳混合ワクチン市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のジフテリア・破傷風・百日咳混合ワクチン市場規模(タイプ別、アプリケーション別)
- 主要国別のジフテリア・破傷風・百日咳混合ワクチン市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのジフテリア・破傷風・百日咳混合ワクチン市場規模(タイプ別、アプリケーション別)
- 主要国別のジフテリア・破傷風・百日咳混合ワクチン市場規模(トルコ、サウジアラビア)
・企業情報
Sanofi Pasteur、GSK、Mitsubishi Tanabe Pharma、KM Biologics、Wuhan Institute of Biological Products、Walvax Biotechnology、Chengdu Institute of Biological Products、Minhai Biotechnology
・産業チェーン及び販売チャネル分析
- ジフテリア・破傷風・百日咳混合ワクチンの産業チェーン分析
- ジフテリア・破傷風・百日咳混合ワクチンの原材料
- ジフテリア・破傷風・百日咳混合ワクチンの生産プロセス
- ジフテリア・破傷風・百日咳混合ワクチンの販売及びマーケティング
- ジフテリア・破傷風・百日咳混合ワクチンの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ジフテリア・破傷風・百日咳混合ワクチンの産業動向
- ジフテリア・破傷風・百日咳混合ワクチンのマーケットドライバー
- ジフテリア・破傷風・百日咳混合ワクチンの課題
- ジフテリア・破傷風・百日咳混合ワクチンの阻害要因
・主な調査結果

Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Diphtheria, Tetanus, and Pertussis Combined Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Diphtheria, Tetanus, and Pertussis Combined Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Diphtheria, Tetanus, and Pertussis Combined Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Diphtheria, Tetanus, and Pertussis Combined Vaccine include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products and Minhai Biotechnology, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Diphtheria, Tetanus, and Pertussis Combined Vaccine manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Diphtheria, Tetanus, and Pertussis Combined Vaccine market. Further, it explains the major drivers and regional dynamics of the global Diphtheria, Tetanus, and Pertussis Combined Vaccine market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Diphtheria, Tetanus, and Pertussis Combined Vaccine Segment by Type
Inactivated Vaccine
Other
Diphtheria, Tetanus, and Pertussis Combined Vaccine Segment by Application
12 Months Below
12 Months Above
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Diphtheria, Tetanus, and Pertussis Combined Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Diphtheria, Tetanus, and Pertussis Combined Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Diphtheria, Tetanus, and Pertussis Combined Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Diphtheria, Tetanus, and Pertussis Combined Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Diphtheria, Tetanus, and Pertussis Combined Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Diphtheria, Tetanus, and Pertussis Combined Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Diphtheria, Tetanus, and Pertussis Combined Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products and Minhai Biotechnology, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Diphtheria, Tetanus, and Pertussis Combined Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Diphtheria, Tetanus, and Pertussis Combined Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diphtheria, Tetanus, and Pertussis Combined Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

レポート目次

1 Study Coverage
1.1 Diphtheria, Tetanus, and Pertussis Combined Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Inactivated Vaccine
1.2.3 Other
1.3 Market by Application
1.3.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 12 Months Below
1.3.3 12 Months Above
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Region
2.4.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Diphtheria, Tetanus, and Pertussis Combined Vaccine by Region (2023-2028)
2.5 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Region
2.5.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Region (2017-2022)
2.5.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Manufacturers
3.1.1 Global Top Diphtheria, Tetanus, and Pertussis Combined Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Diphtheria, Tetanus, and Pertussis Combined Vaccine in 2021
3.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Manufacturers
3.2.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue in 2021
3.3 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Type
4.1.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Type
4.2.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Price by Type
4.3.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Price by Type (2017-2022)
4.3.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Application
5.1.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Application
5.2.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Price by Application
5.3.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Price by Application (2017-2022)
5.3.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Type
6.1.1 North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Type (2017-2028)
6.1.2 North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Type (2017-2028)
6.2 North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Application
6.2.1 North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Application (2017-2028)
6.2.2 North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Application (2017-2028)
6.3 North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Country
6.3.1 North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Country (2017-2028)
6.3.2 North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Type
7.1.1 Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Type (2017-2028)
7.1.2 Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Type (2017-2028)
7.2 Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Application
7.2.1 Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Application (2017-2028)
7.2.2 Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Application (2017-2028)
7.3 Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Country
7.3.1 Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Country (2017-2028)
7.3.2 Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Type
8.1.1 Asia Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Application
8.2.1 Asia Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Region
8.3.1 Asia Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Type
9.1.1 Latin America Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Type (2017-2028)
9.2 Latin America Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Application
9.2.1 Latin America Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Application (2017-2028)
9.3 Latin America Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Country
9.3.1 Latin America Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Type
10.1.1 Middle East and Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Application
10.2.1 Middle East and Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Country
10.3.1 Middle East and Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Corporation Information
11.1.2 Sanofi Pasteur Overview
11.1.3 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis Combined Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Pasteur Recent Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Overview
11.2.3 GSK Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GSK Diphtheria, Tetanus, and Pertussis Combined Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Mitsubishi Tanabe Pharma
11.3.1 Mitsubishi Tanabe Pharma Corporation Information
11.3.2 Mitsubishi Tanabe Pharma Overview
11.3.3 Mitsubishi Tanabe Pharma Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Mitsubishi Tanabe Pharma Diphtheria, Tetanus, and Pertussis Combined Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Mitsubishi Tanabe Pharma Recent Developments
11.4 KM Biologics
11.4.1 KM Biologics Corporation Information
11.4.2 KM Biologics Overview
11.4.3 KM Biologics Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 KM Biologics Diphtheria, Tetanus, and Pertussis Combined Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 KM Biologics Recent Developments
11.5 Wuhan Institute of Biological Products
11.5.1 Wuhan Institute of Biological Products Corporation Information
11.5.2 Wuhan Institute of Biological Products Overview
11.5.3 Wuhan Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Wuhan Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Wuhan Institute of Biological Products Recent Developments
11.6 Walvax Biotechnology
11.6.1 Walvax Biotechnology Corporation Information
11.6.2 Walvax Biotechnology Overview
11.6.3 Walvax Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Walvax Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Walvax Biotechnology Recent Developments
11.7 Chengdu Institute of Biological Products
11.7.1 Chengdu Institute of Biological Products Corporation Information
11.7.2 Chengdu Institute of Biological Products Overview
11.7.3 Chengdu Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Chengdu Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Chengdu Institute of Biological Products Recent Developments
11.8 Minhai Biotechnology
11.8.1 Minhai Biotechnology Corporation Information
11.8.2 Minhai Biotechnology Overview
11.8.3 Minhai Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Minhai Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Minhai Biotechnology Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Diphtheria, Tetanus, and Pertussis Combined Vaccine Industry Chain Analysis
12.2 Diphtheria, Tetanus, and Pertussis Combined Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Mode & Process
12.4 Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales and Marketing
12.4.1 Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Channels
12.4.2 Diphtheria, Tetanus, and Pertussis Combined Vaccine Distributors
12.5 Diphtheria, Tetanus, and Pertussis Combined Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Diphtheria, Tetanus, and Pertussis Combined Vaccine Industry Trends
13.2 Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Drivers
13.3 Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Challenges
13.4 Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Restraints
14 Key Findings in The Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer